How Migraine Medications Are Tested

How Migraine Medications Are Tested

Cerebral Torque

1. Testing Immediate Relief Medications (Acute Treatment)

What's Being Tested Previous Standards Current Standards
How Often Patients Need to Have Migraine Attacks to Join the Study 1-6 migraine attacks per month 2-8 migraine attacks per month, <15 headache days
How Success is Measured (primary endpoint)

Whether migraine attack resolved at 2 hours

Whether pain is completely gone at 2 hours AND most bothersome symptom
Additional Success Measures Just pain relief • Complete pain relief
• Relief from most bothersome symptom
• Whether relief lasts for 24-48 hours
Side Effect Tracking Basic tracking Detailed reporting of all side effects

2. Testing Preventive Medications

What's Being Tested Previous Standards Current Standards
Who Can Participate People with 2-6 migraine attacks monthly People with up to 15 migraine attacks monthly
How Success is Measured (primary endpoint) Counting fewer attacks Either:
• Fewer migraine attack days per month
• At least 50% reduction in migraine days (should be the secondary endpoint, if not the primary)

3. Special Cases

For People with Chronic Migraine

What's Important Details
Who Can Participate People can be included even if they have medication overuse/adaptation headache
Success Measures (primary endpoint) Reduction in number of moderate/severe headache days
Additional Benefits (secondary endpoint) Whether migraine attacks become less frequent overall (conversion to episodic migraine)

For Children and Adolescents

What's Important Details
Age Groups Ages 6-17 allowed to participate
Special Requirements • Must have had migraine attacks for at least 6 months
• Parents can help report symptoms
• Studies must run year-round (not just during school)

For Migraine with Visual/Sensory/Speech or Language Symptoms (Aura)

What's Important Details
Minimum Requirement At least one migraine with aura monthly
Success Measures • How often auras occur (primary endpoint)
• How often headaches follow the aura (secondary endpoint)
Back to blog
  • Global Migraine Trends Analysis

    Global Migraine Trends Analysis

    Cerebral Torque

    A comprehensive 30-year analysis reveals that migraine affects approximately 1 in 7 people globally, with cases increasing by 58% between 1990 and 2021. While women show higher overall prevalence, men's...

    Global Migraine Trends Analysis

    Cerebral Torque

    A comprehensive 30-year analysis reveals that migraine affects approximately 1 in 7 people globally, with cases increasing by 58% between 1990 and 2021. While women show higher overall prevalence, men's...

  • How Migraine Medications Are Tested

    How Migraine Medications Are Tested

    Cerebral Torque

    Ever wondered how migraine medications are proven safe and effective? This is the article for you.

    How Migraine Medications Are Tested

    Cerebral Torque

    Ever wondered how migraine medications are proven safe and effective? This is the article for you.

  • Resistant migraine (ResM) Vs Refractory migraine (RefM) Vs Non-resistant/non-refractory migraine (NRNRM)

    Resistant migraine (ResM) Vs Refractory migrain...

    Cerebral Torque

    The REFINE study showed that resistant migraine (ResM) and refractory migraine (RefM) represent distinct clinical entities with progressively increasing burden of comorbidities (Table 1). 

    Resistant migraine (ResM) Vs Refractory migrain...

    Cerebral Torque

    The REFINE study showed that resistant migraine (ResM) and refractory migraine (RefM) represent distinct clinical entities with progressively increasing burden of comorbidities (Table 1). 

  • Aura Characteristics in Migraine Disease

    Aura Characteristics in Migraine Disease

    Cerebral Torque

    Understanding Migraine with Aura A study published in Cephalalgia sheds new light on migraine with aura (MwA), examining data from 272 patients across Italian headache centers. The research reveals that...

    Aura Characteristics in Migraine Disease

    Cerebral Torque

    Understanding Migraine with Aura A study published in Cephalalgia sheds new light on migraine with aura (MwA), examining data from 272 patients across Italian headache centers. The research reveals that...

1 of 4